Hims’ Super Bowl ad has drawn criticism from lawmakers — and now Novo Nordisk
Novo Nordisk hit back at telehealth company Hims’ controversial Super Bowl commercial touting cheaper versions of brand-name weight loss drugs. The Danish pharma company behind blockbuster shots Ozempic and Wegovy ran its ...
Novo Nordisk hit back at telehealth company Hims’ controversial Super Bowl commercial touting cheaper versions of brand-name weight loss drugs.
The Danish pharma company behind blockbuster shots Ozempic and Wegovy ran its ...
